125 related articles for article (PubMed ID: 23994641)
1. Physicochemical characterization and in vitro permeation of an indirubin derivative.
Heshmati N; Wagner B; Cheng X; Scholz T; Kansy M; Eisenbrand G; Fricker G
Eur J Pharm Sci; 2013 Nov; 50(3-4):467-75. PubMed ID: 23994641
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of oral bioavailability of E804 by self-nanoemulsifying drug delivery system (SNEDDS) in rats.
Heshmati N; Cheng X; Eisenbrand G; Fricker G
J Pharm Sci; 2013 Oct; 102(10):3792-9. PubMed ID: 23934779
[TBL] [Abstract][Full Text] [Related]
3. Modulation of glioma-inflammation crosstalk profiles in human glioblastoma cells by indirubin-3'-(2,3 dihydroxypropyl)-oximether (E804) and 7-bromoindirubin-3'-oxime (7BIO).
Scobie MR; Houke HR; Rice CD
Chem Biol Interact; 2019 Oct; 312():108816. PubMed ID: 31505164
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo evaluations of the performance of an indirubin derivative, formulated in four different self-emulsifying drug delivery systems.
Heshmati N; Cheng X; Dapat E; Sassene P; Eisenbrand G; Fricker G; Müllertz A
J Pharm Pharmacol; 2014 Nov; 66(11):1567-75. PubMed ID: 24961657
[TBL] [Abstract][Full Text] [Related]
5. An indirubin derivative, E804, exhibits potent angiosuppressive activity.
Chan YK; Kwok HH; Chan LS; Leung KS; Shi J; Mak NK; Wong RN; Yue PY
Biochem Pharmacol; 2012 Mar; 83(5):598-607. PubMed ID: 22178720
[TBL] [Abstract][Full Text] [Related]
6. E804 induces growth arrest, differentiation and apoptosis of glioblastoma cells by blocking Stat3 signaling.
Zhang Y; Du Z; Zhuang Z; Wang Y; Wang F; Liu S; Wang H; Feng H; Li H; Wang L; Zhang X; Hao A
J Neurooncol; 2015 Nov; 125(2):265-75. PubMed ID: 26386687
[TBL] [Abstract][Full Text] [Related]
7. Indirubin-3'-(2,3 dihydroxypropyl)-oximether (E804) is a potent modulator of LPS-stimulated macrophage functions.
Babcock AS; Anderson AL; Rice CD
Toxicol Appl Pharmacol; 2013 Jan; 266(1):157-66. PubMed ID: 23107598
[TBL] [Abstract][Full Text] [Related]
8. Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells.
Nam S; Buettner R; Turkson J; Kim D; Cheng JQ; Muehlbeyer S; Hippe F; Vatter S; Merz KH; Eisenbrand G; Jove R
Proc Natl Acad Sci U S A; 2005 Apr; 102(17):5998-6003. PubMed ID: 15837920
[TBL] [Abstract][Full Text] [Related]
9. Lipid-based oral delivery systems for skin deposition of a potential chemopreventive DIM derivative: characterization and evaluation.
Boakye CH; Patel K; Patel AR; Faria HA; Zucolotto V; Safe S; Singh M
Drug Deliv Transl Res; 2016 Oct; 6(5):526-39. PubMed ID: 27405772
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the absorption mechanism of solubilized curcumin using Caco-2 cell monolayers.
Yu H; Huang Q
J Agric Food Chem; 2011 Sep; 59(17):9120-6. PubMed ID: 21805974
[TBL] [Abstract][Full Text] [Related]
11. Water-soluble cationic derivatives of indirubin, the active anticancer component from Indigo naturalis.
Ginzinger W; Egger A; Mühlgassner G; Arion VB; Jakupec MA; Galanski M; Berger W; Keppler BK
Chem Biodivers; 2012 Oct; 9(10):2175-85. PubMed ID: 23081917
[TBL] [Abstract][Full Text] [Related]
12. Physicochemical and biopharmaceutical characterization of endo-2-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-2,3-dihydro-1H-benz[e]isoindol-1-one (CR3124) a novel potent 5-HT3 receptor antagonist.
Cappelli A; Travagli V; Zanardi I; Anzini M; Giorgi G; Donati A; Aggravi M; Casolaro M; Fresta M; Paccagnini E; Makovec F; Vomero S
J Pharm Sci; 2006 Dec; 95(12):2706-21. PubMed ID: 16924684
[TBL] [Abstract][Full Text] [Related]
13. Physicochemical profiling (solubility, permeability and charge state).
Avdeef A
Curr Top Med Chem; 2001 Sep; 1(4):277-351. PubMed ID: 11899112
[TBL] [Abstract][Full Text] [Related]
14. Assessment of cell viability and permeation enhancement in presence of lipid-based self-emulsifying drug delivery systems using Caco-2 cell model: Polysorbate 80 as the surfactant.
Bu P; Ji Y; Narayanan S; Dalrymple D; Cheng X; Serajuddin AT
Eur J Pharm Sci; 2017 Mar; 99():350-360. PubMed ID: 28024890
[TBL] [Abstract][Full Text] [Related]
15. Indirubin 3'-(O-oxiran-2-ylmethyl)oxime: a novel anticancer agent.
Ichimaru Y; Saito H; Uchiyama T; Metori K; Tabata K; Suzuki T; Miyairi S
Bioorg Med Chem Lett; 2015 Apr; 25(7):1403-6. PubMed ID: 25765906
[TBL] [Abstract][Full Text] [Related]
16. Investigation of Molecular Properties that Influence the Permeability and Oral Bioavailability of Major β-Boswellic Acids.
Sharma T; Jana S
Eur J Drug Metab Pharmacokinet; 2020 Apr; 45(2):243-255. PubMed ID: 31786725
[TBL] [Abstract][Full Text] [Related]
17. Absorption of poorly water soluble drugs subject to apical efflux using phospholipids as solubilizers in the Caco-2 cell model.
Kapitza SB; Michel BR; van Hoogevest P; Leigh ML; Imanidis G
Eur J Pharm Biopharm; 2007 Apr; 66(1):146-58. PubMed ID: 17071065
[TBL] [Abstract][Full Text] [Related]
18. Permeability profiles of M-alkoxysubstituted pyrrolidinoethylesters of phenylcarbamic acid across caco-2 monolayers and human skin.
Gyürösiová L; Laitinen L; Raiman J; Cizmárik J; Sedlárová E; Hirvonen J
Pharm Res; 2002 Feb; 19(2):162-8. PubMed ID: 11883643
[TBL] [Abstract][Full Text] [Related]
19. Advantage of the Dissolution/Permeation System for Estimating Oral Absorption of Drug Candidates in the Drug Discovery Stage.
Miyaji Y; Fujii Y; Takeyama S; Kawai Y; Kataoka M; Takahashi M; Yamashita S
Mol Pharm; 2016 May; 13(5):1564-74. PubMed ID: 27031624
[TBL] [Abstract][Full Text] [Related]
20. Quantitative biopharmaceutics classification system: the central role of dose/solubility ratio.
Rinaki E; Valsami G; Macheras P
Pharm Res; 2003 Dec; 20(12):1917-25. PubMed ID: 14725354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
